Search

everythinglearnresearchcommunity

for

Search:↓

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Hair follicles could help develop eye treatments by studying immune responses.

Alopecia areata patients often have undetected thyroid issues, so routine thyroid screening is recommended.

Non-immune factors play a significant role in alopecia areata.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Hair loss in male pattern baldness is linked to changes in immune cell behavior around hair follicles.

Lacrimal gland inflammation and alopecia areata can happen together due to autoimmune issues.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

A man with severe hair loss regrew hair after hormone treatment.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

High levels of HSP70 and IL-15 are linked to more severe alopecia areata.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

A 9-year-old girl developed type 1 diabetes and alopecia after being treated for a rare kidney disease.

Patients with Type 1 diabetes should be screened for pernicious anemia.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Blocking LFA-1 prevents hair loss in mice.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

The woman's facial symptoms are best explained by primary Sjögren’s Syndrome.

CD44 variant changes start alopecia areata, but don't maintain it.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

Hair follicles in nonsegmental vitiligo are better protected from immune attacks than in alopecia areata.

BTNL2 helps protect hair follicles from immune attacks.

Thorough history taking is crucial for diagnosing hypothyroidism in rheumatoid arthritis patients.